Skip to main content
Earnings Labs
RN

Rein Therapeutics Inc. (RNTX)

NASDAQ·Healthcare·Biotechnology

$0.62

+5.91%

Mkt Cap $47.62M

Analyst Ratings

Buy

2

Hold

0

Sell

0

Price Target (1 analysts)

$6.00

Range $6.00 – $6.00

Implied Upside

+861.7%

Consensus $6.00 vs current $0.62